StockData
CytoMed Therapeutics Ltd logo

CytoMed Therapeutics Ltd (GDTC) stock

GDTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 4/30
$0.76−0.02 (-2.33%)

Close on Nov 20, 2026Market cap $8.93MP/E –Yield –

CytoMed Therapeutics net income

Net income is the profit left for shareholders after every expense, interest and tax.

For fiscal 2025 it was -3.98M SGD. The highest annual figure on record is -1.94M SGD in fiscal 2020.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-3.98M SGD–
FY2024Dec 31, 2024-2.52M SGD–
FY2023Dec 31, 2023-4.13M SGD–
FY2022Dec 31, 2022-3.13M SGD–
FY2021Dec 31, 2021-2.05M SGD–
FY2020Dec 31, 2020-1.94M SGD–

More CytoMed Therapeutics figures

See a number that looks wrong?